Comparative efficacy of repurposed drugs lopinavir-ritonavir and darunavir-ritonavir in hospitalised COVID-19 patients: insights from a tertiary centre cohort
BackgroundDrug repurposing has become a widely adopted strategy to minimise research time, costs, and associated risks. Combinations of protease inhibitors such as lopinavir and darunavir with ritonavir have been repurposed as treatments for COVID-19. Although lopinavir-ritonavir (LPV/r) and darunav...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2025-01-01
|
| Serier: | Frontiers in Cellular and Infection Microbiology |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/articles/10.3389/fcimb.2024.1496176/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|